SCHEMBL29352030

SCHEMBL29352030

CNc1ccc(Oc2ccc(-c3ccc(F)cc3)nc2)nc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ NTRK1 P04629 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ CSF1R P07333 1/20 0.38
▸ RET P07949 1/20 0.38
▸ MET P08581 1/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ PDGFRA P16234 1/20 0.38
▸ FLT3 P36888 1/20 0.38
▸ MAPK8 P45983 1/20 0.38
▸ CDK8 P49336 1/20 0.38
▸ MAP2K1 Q02750 1/20 0.38
▸ MAP4K2 Q12851 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ NTRK3 Q16288 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ AURKB Q96GD4 1/20 0.38
▸ NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22529924 1.00 AURKA (0.38) AURKAABL1NTRK1LCKCSF1R
SCHEMBL22529946 0.88 CYP11B1 (0.47) NPC1RAB9ASMN1; SMN2GRM5MEN1
SCHEMBL22529941 0.86 SCN9A (0.41) MAPK14NPC1CASP3RAB9ASMN1; SMN2
SCHEMBL29352386 0.86 SCN9A (0.41) MAPK14NPC1CASP3RAB9ASMN1; SMN2
SCHEMBL26140408 0.85 MEN1 (0.39) AURKAABL1NTRK1LCKCSF1R
SCHEMBL22529957 0.82 MEN1 (0.43) AURKAABL1NTRK1LCKCSF1R
SCHEMBL29349922 0.82 MEN1 (0.43) AURKAABL1NTRK1LCKCSF1R
SCHEMBL29350344 0.81 MAPK8 (0.38) AURKAABL1NTRK1LCKCSF1R
SCHEMBL22530943 0.81 MAPK8 (0.38) AURKAABL1NTRK1LCKCSF1R
SCHEMBL22531085 0.79 ALDH1A1 (0.49) AURKAABL1NTRK1LCKCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994001-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-11-22 — — CN disclosed
CN-113966324-B NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-09-03 — — CN disclosed
EP-3953335-A1 INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS Cellestia Biotech AG (CH) 2022-02-16 — — EP disclosed
CN-113966324-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2022-01-21 — — CN disclosed
Send feedback